Suppr超能文献

希氏束起搏后房室结消融治疗难治性房性快速性心律失常的长期结果

Long-Term Results of Atrioventricular Node Ablation After His Bundle Pacing in Uncontrolled Atrial Tachyarrhythmias.

作者信息

Moraleda-Salas María Teresa, Erkoreka-Gasituaga Ane, Perea-Alfaro Carlos, Esteve-Ruiz Irene, Arce-León Álvaro, Carreño-Lineros José Miguel, Amigo-Otero Emilio, Moraleda-Salas María Del Mar, Camacho-Freire Santiago, Navarro-Roldan Francisco, Moriña-Vázquez Pablo

机构信息

Arrhythmia Unit, Department of Cardiology, Hospital Juan Ramon Jimenez, Huelva, Spain.

Department of Cardiology, Hospital Juan Ramon Jimenez, Huelva, Spain.

出版信息

Pacing Clin Electrophysiol. 2025 Jun 19. doi: 10.1111/pace.70000.

Abstract

INTRODUCTION

In the evolving treatment of atrial fibrillation (AF), atrioventricular (AV) node ablation is being reconsidered as an early option for patients with inadequate AF control and limited cure potential. Although interest in physiological pacing is growing, concerns about the long-term safety of permanent His bundle pacing (p-HBP) persist. Our current study aims to evaluate the long-term outcomes of patients who underwent AV node ablation and p-HBP, focusing on left ventricular ejection fraction (LVEF), NYHA class, readmissions, and pacing parameters.

METHODS

This descriptive observational study involved patients with uncontrolled permanent atrial arrhythmias who were eligible for heart rate (HR) control (between January 2019 and July 2020) and underwent p-HBP and AV node ablation, followed during a near 4-year period.

RESULTS

We conducted a long-term follow-up study with a median duration of 47 months on 32 patients who received p-HBP followed by AV node ablation. The average age was 77 years, predominantly female (65.6%), with a high prevalence of hypertension (90.6%). The main indications for ablation were uncontrolled AF (59.4%) and atypical atrial flutter (37.5%). At baseline, the median LVEF was 60%. Notably, LVEF improved significantly from 45% to 50% in those with reduced baseline function (p < 0.05). NYHA class improvements were also observed over time. The His thresholds remained similar during long-term follow-up, being 1.25 V at 0.4 ms (1.25-2.4 V at 0.4 ms) before AV node ablation and 1.30 V at 0.4 ms (0.75-2.25 V at 0.4 ms), p = 0.89, at long-term follow-up. The impedances remained stable. No complications related to the pacemaker occurred. Number of medications per patient for HR control significantly decreased from 1.6 to 0.37 (p < 0.05), while hospital admissions for tachyarrhythmias dropped markedly. There was one death during the follow-up due to cancer, but conclusions regarding mortality are limited by the small sample size.

CONCLUSIONS

AV node ablation and p-HBP significantly improve functional class and LVEF, with benefits maintained over time. Patients experience fewer emergency visits and reduced HR medication. Pacing parameters remained stable during long-term follow-up.

摘要

引言

在心房颤动(AF)不断发展的治疗中,房室(AV)结消融正被重新视为房颤控制不佳且治愈潜力有限的患者的早期治疗选择。尽管对生理性起搏的兴趣日益浓厚,但对永久性希氏束起搏(p-HBP)长期安全性的担忧依然存在。我们当前的研究旨在评估接受AV结消融和p-HBP治疗的患者的长期预后,重点关注左心室射血分数(LVEF)、纽约心脏协会(NYHA)心功能分级、再入院情况和起搏参数。

方法

这项描述性观察性研究纳入了2019年1月至2020年7月期间符合心率(HR)控制条件、患有无法控制的永久性房性心律失常且接受了p-HBP和AV结消融的患者,并对其进行了近4年的随访。

结果

我们对32例接受p-HBP后行AV结消融的患者进行了中位时长为47个月的长期随访研究。患者平均年龄为77岁,以女性为主(65.6%),高血压患病率较高(90.6%)。消融的主要适应证为无法控制的房颤(59.4%)和非典型房扑(37.5%)。基线时,中位LVEF为60%。值得注意的是,基线功能降低的患者的LVEF从45%显著提高到了50%(p<0.05)。随着时间的推移,NYHA心功能分级也有所改善。长期随访期间希氏束阈值保持相似,AV结消融前在0.4毫秒时为1.25伏(0.4毫秒时为1.25 - 2.4伏),长期随访时在0.4毫秒时为1.30伏(0.4毫秒时为0.75 - 2.25伏),p = 0.89。阻抗保持稳定。未发生与起搏器相关的并发症。每位患者用于控制心率的药物数量从1.6种显著减少至0.37种(p<0.05),同时快速心律失常的住院次数明显下降。随访期间有1例因癌症死亡,但由于样本量小,关于死亡率的结论有限。

结论

AV结消融和p-HBP可显著改善心功能分级和LVEF,且随着时间推移疗效得以维持。患者的急诊就诊次数减少,控制心率的药物用量降低。长期随访期间起搏参数保持稳定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验